Excitatory Amino Acid Neurotoxicity in Rat Brain Slices

  • J. Garthwaite
  • G. Garthwaite
  • G. D. Williams
Conference paper
Part of the Research and Perspectives in Neurosciences book series (NEUROSCIENCE)


The evidence continues to mount that excessive or prolonged activation of excitatory amino acid (EAA) receptors in the central nervous system contributes to the death of neurones taking place in certain neuropathological conditions of the types that affect humans (Olney 1978; Meldrum and Garthwaite 1990). These conditions include cerebral ischaemia, hypoglycaemia and trauma in which an endogenous agonist, presumably glutamate, is believed to be the culprit. However, following the discoveries that ingestion of the glutamate receptor agonists, domoic acid (in mussels), β-N-oxalylamino-L-alanine (BOAA, in chick peas) and β-N-methyl-amino-L-alanine (BMAA, in the seeds of a false sago palm, Cycas) induces neurodegeneration, attention is also being directed towards glutamate-like chemicals in the environment as neurotoxic agents.


Purkinje Cell Excitatory Amino Acid Domoic Acid Golgi Cell Excitatory Amino Acid Receptor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Ben-Ari Y (1985) Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neuroscience 14:375–403.PubMedCrossRefGoogle Scholar
  2. Crepel F, Dhanjal SS, Sears TA (1982) Effect of glutamate, aspartate and related derivatives on cerebellar Purkinje cell dendrites in the rat: an in vitro study. J Physiol (Lond.) 329:297–317.Google Scholar
  3. Ellren K, Lehmann A (1989) Calcium dependency of N-methyl-D-aspartate toxicity in slices from the immature rat hippocampus. Neuroscience 32:371–379.PubMedCrossRefGoogle Scholar
  4. Foster GA, Roberts PJ, Rowlands GJ, Sharif NA (1981) Ontogeny of neurochemical markers for glutamatergic neurons in cerebellum: implications for development of kainate neurotoxicity. Br. J. Pharmacol. 73:235P.Google Scholar
  5. Garthwaite G, Garthwaite J (1986a) In vitro neurotoxicity of excitatory amino acid analogues during cerebellar development. Neuroscience 17:755–767.PubMedCrossRefGoogle Scholar
  6. Garthwaite G, Garthwaite J (1986b) Neurotoxicity of excitatory amino acid receptor agonists in rat cerebellar slices: dependence on extracellular calcium concentration. Neurosci. Lett. 66:193–198.PubMedCrossRefGoogle Scholar
  7. Garthwaite G, Garthwaite J (1986c) Amino acid neurotoxicity: intracellular sites of calcium accumulation associated with the onset of irreversible damage to rat cerebellar neurones in vitro. Neurosci. Lett. 71:53–58.PubMedCrossRefGoogle Scholar
  8. Garthwaite G, Garthwaite J (1987) Receptor-linked ionic channels mediate N-methyl-D-aspartate neurotoxicity in rat cerebellar slices. Neurosci. Lett. 83:241–246.PubMedCrossRefGoogle Scholar
  9. Garthwaite G, Garthwaite J (1989a) Neurotoxicity of excitatory amino acid receptor agonists in young rat hippocampal slices. J. Neurosci. Methods 29:33–42.PubMedCrossRefGoogle Scholar
  10. Garthwaite G, Garthwaite J (1989b) Differential dependence on Ca2+ of N-methyl-D-aspartate and quisqualate neurotoxicity in young rat hippocampal slices. Neurosci. Lett. 97:316–322.PubMedCrossRefGoogle Scholar
  11. Garthwaite G, Garthwaite J (1989c) Quisqualate neurotoxicity: a delayed, CNQX-sensitive process triggered by a CNQX-insensitive mechanism in yound rat hippocampal slizes. Neurosci. Lett. 99:113–118.PubMedCrossRefGoogle Scholar
  12. Garthwaite G, Hajos F, Garthwaite J (1986) Ionic requirements for neurotoxic effects of excitatory amino acid analogues in rat cerebellar slices. Neuroscience 18:437–447.PubMedCrossRefGoogle Scholar
  13. Garthwaite G, Yrnini B Jr, Garthwaite J (1987) Selective loss of Purkinje and granule cell responsiveness to N-methyl-D-aspartate in rat cerebellum during development. Devl. Brain Res. 36:288–292.CrossRefGoogle Scholar
  14. Garthwaite G, Williams GD, Garthwaite J (1990) AMPA mimics quisqualate neurotoxicity in slices of young rat cerebellum and hippocampus. Neurosci. Lett. Suppl. 38:S78.Google Scholar
  15. Garthwaite J (1989) NMDA receptors, neuronal development and neuronal degeneration. In: Watkins JC, Collingridge GL (eds.) The NMDA receptor. Oxford University Press, pp 187-205.Google Scholar
  16. Garthwaite J, Garthwaite G, Hajos F (1986) Amino acid neurotoxicity: relationship to neuronal depolarization in rat cerebellar slices. Neuroscience 18:449–460.PubMedCrossRefGoogle Scholar
  17. Gill R, Foster AC, Woodruff GN (1987) Systemic administration of MK-801 protects against ischemia induced-hippocampal neurodegeneration in the gerbil. J. Neurosci. 7:3343–3349.PubMedGoogle Scholar
  18. Hajos F, Garthwaite G, Garthwaite J (1986) Reversible and irreversible neuronal damage caused by excitatory amino acid analogues in rat cerebellar slices. Neuroscience 18:417–436.PubMedCrossRefGoogle Scholar
  19. Honoré T, Lauridsen J, Krogsgaard-Larsen P (1982) The binding of [3H]AMPA, a structural analogue of glutamic acid, to rat brain membranes. J. Neurochem. 38:173–178.PubMedCrossRefGoogle Scholar
  20. Iino M, Ozawa S, Tsuzuki K (1990) Permeation of calcium through excitatory amino acid receptor channels in cultured rat hippocampal neurones. J. Physiol. (Lond.) 424:151–165.Google Scholar
  21. MacDermott AB, Mayer ML, Westbrook GL, Smith SJ, Barker JL (1986) NMDA-receptor activation increases cytoplasmic calcium concentration in cultured spinal cord neurones. Nature 321:519–522.PubMedCrossRefGoogle Scholar
  22. Mayer ML, Miller RJ (1990) Excitatory amino acid receptors, second messengers and regulation of intracellular Ca2+ in mammalian neurons. Trends Pharmacol. Sci. 11:254–260.PubMedCrossRefGoogle Scholar
  23. Meldrum BS, Garthwaite J (1990) Excitatory amino acid neurotoxicity and neurodegeneration disease. Trends Pharmacol. Sci. 11:379–387.PubMedCrossRefGoogle Scholar
  24. Nielsen EO, Drejer J, Cha J-HJ, Young AB, Honore T (1990) Autoradiographic characterization and localization of quisqualate binding sites in rat brain using the antagonist [3H]6-cyano-7-nitroquinoxaline-2,3-dione: comparison with (R,S)-[3H]a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid binding sites. J. Neurochem. 54:686–695.PubMedCrossRefGoogle Scholar
  25. Olney JW (1978) Neurotoxicity of excitatory amino acids. In: McGeer EG, Olney JW, McGeer PL (eds) Kainic acid as a tool in neurobiology. Raven Press, New York, pp 95–121.Google Scholar
  26. Scharfman HE, Schwartzkroin PA (1989) Protection of dentate hilar cells from prolonged stimulation by intracellular calcium chelation. Science 246:257–260.PubMedCrossRefGoogle Scholar
  27. Sheardown MJ, Nielsen EO, Hansen AJ, Jacobsen P, Honoré T (1990) 2,3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: a neuroprotectant for cerebral ischemia. Science 247:571–574.PubMedCrossRefGoogle Scholar
  28. Simon RP, Swan JH, Griffiths T, Meldrum BS (1984) Blockade of N-methyl-D-aspartate receptors may protect against ischemic damage in the brain. Science 226:850–852.PubMedCrossRefGoogle Scholar
  29. Sladaczek F, Pin J-P, Recasens M, Bockaert J, Weiss S (1985) Glutamate stimulates inositol formation in striatal neurones. Nature 317:717–719.CrossRefGoogle Scholar
  30. Sugiyama H, Ito I, Hirono C (1987) A new type of glutamate receptor linked to inositol phospholipid metabolism. Nature 325:531–533.PubMedCrossRefGoogle Scholar
  31. Whittemore ER, Koerner JF (1989) Novel recognition site for L-quisqualate sensitizes neurons to depolarization by L-2-amino-4-phosphonobutanoate (L-AP4). Brain Res. 489:146–156.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • J. Garthwaite
  • G. Garthwaite
  • G. D. Williams

There are no affiliations available

Personalised recommendations